Oxygen Nasal Cannula Adult Soft Type

Description

1. Product Overview

The Oxygen Nasal Cannula Adult Soft Type is a medical-grade respiratory device engineered for low-to-medium flow oxygen delivery in adult patients requiring supplemental oxygenation. Its primary industrial application lies within acute care hospitals, long-term care facilities, home healthcare, and emergency medical services (EMS). Manufactured from hypoallergenic, DEHP-free medical polymer, the device offers a superior balance of patient comfort, kink resistance, and flow precision. In a global market increasingly prioritizing infection control, cost efficiency, and patient compliance, this cannula represents a strategically essential component for healthcare procurement systems aiming to reduce complication rates and optimize per-bed consumables expenditure.

2. Key Specifications & Technical Characteristics

• Material Composition: Medical-grade PVC (phthalate-free, DEHP-free) or non-latex thermoplastic elastomer (TPE); nasal prongs of soft silicone.

• Purity / Biocompatibility Grade: ISO 10993 certified; non-cytotoxic, non-irritant, non-sensitizing.

• Physical Characteristics:

  • Tubing length: 2.1 m (±5%) standard

  • Tubing inner diameter: ~3.0 mm

  • Tubing outer diameter: ~5.5 mm

  • Prong length: 12–16 mm (adjustable via swivel)

  • Color: transparent or translucent (light blue / clear)

  • Density of material: 1.20–1.35 g/cm³

• Packaging Options: Individually sealed in medical-grade peel pouch (sterile – EO gas); available in bulk inner cartons of 50 units; master carton of 200 units.

• Shelf Life: 3 years from date of manufacture (when stored in original packaging, ≤40°C, ≤80% RH).

3. Core Industrial Applications

• Primary Industries: Acute care hospitals, skilled nursing facilities, home medical equipment (HME) providers, EMS and ambulatory transport services.

• Specific Operational Use Cases:

  • Post-operative oxygen therapy in general wards

  • Chronic obstructive pulmonary disease (COPD) maintenance

  • EMS pre-hospital stabilization

  • Palliative and long-term home oxygen therapy

• Performance Advantages vs. Alternatives:

  • Softer prong geometry reduces nasal septum pressure injuries by 40% compared to rigid cannulas (internal wear-test data).

  • Kink-resistant tubing maintains consistent flow (1–6 L/min) even during patient movement, minimizing unscheduled nursing interventions.

  • Low dead-space design improves FiO₂ accuracy at lower flow rates, reducing total oxygen consumption by up to 12%.

  • Cost efficiency: 30% lower per-unit price than leading branded equivalents without compromising ISO 80601-2-72 compliance.

4. Competitive Advantages

• Quality Consistency: Manufactured under ISO 13485:2016 certified facility; 100% leak-tested and flow-calibrated per batch. Lot traceability to raw material source.

• Supply Reliability: Dual-sourced raw material buffer stock; 12-month rolling forecast fulfillment capability with ≤98% on-time delivery rate to 50+ countries.

• Logistics Capability: Warehousing hubs in Asia, Europe, and North America enabling 5–7 day lead time for urgent restocks.

• Price Competitiveness: Tiered pricing model reducing effective unit cost by 18–25% for annual volumes above 500,000 units.

• Sustainability: DEHP-free, latex-free; packaging uses recyclable low-density polyethylene (LDPE) with 30% PCR content. Carbon-neutral shipment available for container orders.

• Technical Support: Full IFU (Instructions for Use) in 14 languages; regulatory documentation package (CE MDR, UKCA, NMPA, Saudi FDA, ANVISA) provided upon NDA.

5. Commercial & Supply Information

• Minimum Order Quantity (MOQ): BULK 20MT (approximately 1,200 standard master cartons → 240,000 individual units, assuming 200 units per master carton, 5 kg per carton).

• Loading Capacity (per 20FT container): 18–20 MT (≈ 1,080–1,200 master cartons → 216,000–240,000 units).

• Loading Capacity (per 40FT HC container): 24–26 MT (≈ 1,440–1,560 master cartons → 288,000–312,000 units).